Related Experiment Video
Updated: May 30, 2026
06:38
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
Published on: August 4, 2022
Ocular allergy.
1Division of Ophthalmology, Scripps Clinic, The Scripps Research Institute, La Jolla, California, USA. mfried@scrippsclinic.com
Current Opinion in Allergy and Clinical Immunology
|August 9, 2011
Summary
Ocular allergy management has improved with a better understanding of its immunologic basis and new treatments like mast cell stabilizers and corticosteroids. This enhances physician familiarity and patient outcomes for allergic conjunctivitis.
Area of Science:
- Ophthalmology
- Allergy Immunology
Background:
- Ocular allergy is a common condition managed by various medical specialists.
- Understanding its immunologic basis is crucial for effective diagnosis and treatment.
Purpose of the Study:
- To review the immunologic mechanisms, diagnosis, clinical features, and treatment of ocular allergy.
- To highlight advancements in the management of allergic conjunctivitis.
Main Methods:
- Review of basic and clinical research on ocular allergy.
- Analysis of new pharmacological agents and their efficacy.
Main Results:
- Enhanced understanding of the cellular and mediator roles in ocular allergy.
- Introduction of improved treatments, including potent mast cell stabilizers and low-dose corticosteroids.
- Increased efficacy and safety in ocular allergy treatment.
Conclusions:
- Physicians possess greater familiarity with ocular allergy signs and symptoms.
- Improved understanding of allergic conjunctivitis mechanisms and features.
- Advanced therapeutic tools lead to better patient outcomes.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:22Photoreceptors and Visual Pathways
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
02:06Allergic Reactions
Overview
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...